ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
A new PPAR agonist (GQ-11) modulates impaired inflammation and induces re-epithelization in diabetic wound healing (2018)
Silva, Jacqueline Cavalcante; Pitta, Ivan da Rocha; Pitta, Marina Galdino; Koh, Timothy Jon; Abdalla, Dulcinéia Saes Parra
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Congress of the Brazilian Association of Pharmaceutical Sciences/ABCF. Unidade: FCF
Subjects: DIABETES MELLITUS, AMPUTAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Jacqueline Cavalcante et al. A new PPAR agonist (GQ-11) modulates impaired inflammation and induces re-epithelization in diabetic wound healing. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf. Acesso em: 17 nov. 2024. , 2018
APA
Silva, J. C., Pitta, I. da R., Pitta, M. G., Koh, T. J., & Abdalla, D. S. P. (2018). A new PPAR agonist (GQ-11) modulates impaired inflammation and induces re-epithelization in diabetic wound healing. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf
NLM
Silva JC, Pitta I da R, Pitta MG, Koh TJ, Abdalla DSP. A new PPAR agonist (GQ-11) modulates impaired inflammation and induces re-epithelization in diabetic wound healing [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 47 res. 63.[citado 2024 nov. 17 ] Available from: http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf
Vancouver
Silva JC, Pitta I da R, Pitta MG, Koh TJ, Abdalla DSP. A new PPAR agonist (GQ-11) modulates impaired inflammation and induces re-epithelization in diabetic wound healing [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 47 res. 63.[citado 2024 nov. 17 ] Available from: http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf
Artigo de periodico
Role of an indole-thiazolidiene PPAR pan ligand on actions elicited by G-protein coupled receptor activated neutrophils (2018)
Santin, José Roberto; Machado, Isabel Daufenback; Drewes, Carine C; Kupa, Léonard de Vinci Kanda; Soares, Rodrigo Marcondes; Cavalcanti, Danielle Maia de; Pitta, Ivan da Rocha; Farsky, Sandra Helena Poliselli
Source: Biomedicine & Pharmacotherapy. Unidade: FCF
Subjects: NEUTRÓFILOS, PROTEÍNAS G
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTIN, José Roberto et al. Role of an indole-thiazolidiene PPAR pan ligand on actions elicited by G-protein coupled receptor activated neutrophils. Biomedicine & Pharmacotherapy, v. 105, p. 947-955 , 2018Tradução . . Disponível em: https://doi.org/10.1016/j.biopha.2018.06.056. Acesso em: 17 nov. 2024.
APA
Santin, J. R., Machado, I. D., Drewes, C. C., Kupa, L. de V. K., Soares, R. M., Cavalcanti, D. M. de, et al. (2018). Role of an indole-thiazolidiene PPAR pan ligand on actions elicited by G-protein coupled receptor activated neutrophils. Biomedicine & Pharmacotherapy, 105, 947-955 . doi:10.1016/j.biopha.2018.06.056
NLM
Santin JR, Machado ID, Drewes CC, Kupa L de VK, Soares RM, Cavalcanti DM de, Pitta I da R, Farsky SHP. Role of an indole-thiazolidiene PPAR pan ligand on actions elicited by G-protein coupled receptor activated neutrophils [Internet]. Biomedicine & Pharmacotherapy. 2018 ; 105 947-955 .[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.biopha.2018.06.056
Vancouver
Santin JR, Machado ID, Drewes CC, Kupa L de VK, Soares RM, Cavalcanti DM de, Pitta I da R, Farsky SHP. Role of an indole-thiazolidiene PPAR pan ligand on actions elicited by G-protein coupled receptor activated neutrophils [Internet]. Biomedicine & Pharmacotherapy. 2018 ; 105 947-955 .[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.biopha.2018.06.056
Artigo de periodico
New thiazolidinediones affect endothelial cell activation and angiogenesis (2016)
Rudnicki, Martina; Tripodi, Gustavo Luis; Ferrer, Renila; Boscá, Lisardo; Pitta, Marina G. R; Pitta, Ivan Rocha; Abdalla, Dulcinéia Saes Parra
Source: European Journal of Pharmacology. Unidade: FCF
Subjects: CÉLULAS ENDOTELIAIS, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUDNICKI, Martina et al. New thiazolidinediones affect endothelial cell activation and angiogenesis. European Journal of Pharmacology, v. 782, p. 98-106, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2016.04.038. Acesso em: 17 nov. 2024.
APA
Rudnicki, M., Tripodi, G. L., Ferrer, R., Boscá, L., Pitta, M. G. R., Pitta, I. R., & Abdalla, D. S. P. (2016). New thiazolidinediones affect endothelial cell activation and angiogenesis. European Journal of Pharmacology, 782, 98-106. doi:10.1016/j.ejphar.2016.04.038
NLM
Rudnicki M, Tripodi GL, Ferrer R, Boscá L, Pitta MGR, Pitta IR, Abdalla DSP. New thiazolidinediones affect endothelial cell activation and angiogenesis [Internet]. European Journal of Pharmacology. 2016 ; 782 98-106.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.ejphar.2016.04.038
Vancouver
Rudnicki M, Tripodi GL, Ferrer R, Boscá L, Pitta MGR, Pitta IR, Abdalla DSP. New thiazolidinediones affect endothelial cell activation and angiogenesis [Internet]. European Journal of Pharmacology. 2016 ; 782 98-106.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.ejphar.2016.04.038
Artigo de periodico
New PPAR partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr−/− mice (2016)
Silva, Jacqueline Cavalcante; César, Fernanda Andrade de; Oliveira, Edson Mendes de; Turato, Walter Miguel; Tripodi, Gustavo L; Castilho, Gabriela; Lima, Adriana Machado; Las Heras, Beatriz de; Boscá, Lisardo; Rabello, Marcelo M; Hernandes, Marcelo Zaldini; Pitta, Marina G. R; Pitta, Ivan Rocha; Passarelli, Marisa; Rudnicki, Martina; Abdalla, Dulcinéia Saes Parra
Source: Pharmacological Research. Unidades: FCF, FM
Subjects: ARTERIOSCLEROSE, DOENÇAS CARDIOVASCULARES, EXPRESSÃO GÊNICA, ADIPONECTINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Jacqueline Cavalcante et al. New PPAR partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr−/− mice. Pharmacological Research, v. 104, p. 49-60, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.phrs.2015.12.010. Acesso em: 17 nov. 2024.
APA
Silva, J. C., César, F. A. de, Oliveira, E. M. de, Turato, W. M., Tripodi, G. L., Castilho, G., et al. (2016). New PPAR partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr−/− mice. Pharmacological Research, 104, 49-60. doi:10.1016/j.phrs.2015.12.010
NLM
Silva JC, César FA de, Oliveira EM de, Turato WM, Tripodi GL, Castilho G, Lima AM, Las Heras B de, Boscá L, Rabello MM, Hernandes MZ, Pitta MGR, Pitta IR, Passarelli M, Rudnicki M, Abdalla DSP. New PPAR partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr−/− mice [Internet]. Pharmacological Research. 2016 ; 104 49-60.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.phrs.2015.12.010
Vancouver
Silva JC, César FA de, Oliveira EM de, Turato WM, Tripodi GL, Castilho G, Lima AM, Las Heras B de, Boscá L, Rabello MM, Hernandes MZ, Pitta MGR, Pitta IR, Passarelli M, Rudnicki M, Abdalla DSP. New PPAR partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr−/− mice [Internet]. Pharmacological Research. 2016 ; 104 49-60.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.phrs.2015.12.010
Artigo de periodico
Use of transgenic Aedes aegypti in Brazil: risk perception and assessment (2016)
Andrade, Paulo Paes de; Aragão, Francisco José Lima; Colli, Walter ; Dellagostin, Odir Antonio; Finardi Filho, Flavio ; Hirata, Mario Hiroyuki ; Lira Neto, Amaro de Castro; Melo, Marcia Almeida de; Nepomuceno, Alexandre Lima; Nobrega, Francisco Gorgonio da; Sousa, Gutemberg Delfino; Valicente, Fernando Hercos; Zanettini, Maria Helena Bodanese
Source: Bulletim of the World Health Organization. Unidades: IQ, FCF, ICB
Subjects: AEDES, DENGUE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, Paulo Paes de et al. Use of transgenic Aedes aegypti in Brazil: risk perception and assessment. Bulletim of the World Health Organization, v. 94, p. 766-771, 2016Tradução . . Disponível em: https://doi.org/10.2471/BLT.16.173377. Acesso em: 17 nov. 2024.
APA
Andrade, P. P. de, Aragão, F. J. L., Colli, W., Dellagostin, O. A., Finardi Filho, F., Hirata, M. H., et al. (2016). Use of transgenic Aedes aegypti in Brazil: risk perception and assessment. Bulletim of the World Health Organization, 94, 766-771. doi:10.2471/BLT.16.173377
NLM
Andrade PP de, Aragão FJL, Colli W, Dellagostin OA, Finardi Filho F, Hirata MH, Lira Neto A de C, Melo MA de, Nepomuceno AL, Nobrega FG da, Sousa GD, Valicente FH, Zanettini MHB. Use of transgenic Aedes aegypti in Brazil: risk perception and assessment [Internet]. Bulletim of the World Health Organization. 2016 ; 94 766-771.[citado 2024 nov. 17 ] Available from: https://doi.org/10.2471/BLT.16.173377
Vancouver
Andrade PP de, Aragão FJL, Colli W, Dellagostin OA, Finardi Filho F, Hirata MH, Lira Neto A de C, Melo MA de, Nepomuceno AL, Nobrega FG da, Sousa GD, Valicente FH, Zanettini MHB. Use of transgenic Aedes aegypti in Brazil: risk perception and assessment [Internet]. Bulletim of the World Health Organization. 2016 ; 94 766-771.[citado 2024 nov. 17 ] Available from: https://doi.org/10.2471/BLT.16.173377
Artigo de periodico
Improved nonclinical pharmacokinetics and biodistribution of a new PPAR pan-agonist and COX inhibitor in nanocapsule formulation (2015)
Garcia, Giani Martins; Oliveira,Líliam Teixeira; Pitta, Ivan da Rocha; Lima, Maria do Carmo Alves de; Vilela, José Mário Carneiro; Andrade, Margareth Spangler; Abdalla, Dulcinéia Saes Parra ; Mosqueira, Vanessa Carla Furtado
Source: Journal of Controlled Release. Unidade: FCF
Subjects: FARMACOCINÉTICA, NANOTECNOLOGIA, CÁPSULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GARCIA, Giani Martins et al. Improved nonclinical pharmacokinetics and biodistribution of a new PPAR pan-agonist and COX inhibitor in nanocapsule formulation. Journal of Controlled Release, v. 209, p. 207-218, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.jconrel.2015.04.033. Acesso em: 17 nov. 2024.
APA
Garcia, G. M., Oliveira, L. T., Pitta, I. da R., Lima, M. do C. A. de, Vilela, J. M. C., Andrade, M. S., et al. (2015). Improved nonclinical pharmacokinetics and biodistribution of a new PPAR pan-agonist and COX inhibitor in nanocapsule formulation. Journal of Controlled Release, 209, 207-218. doi:10.1016/j.jconrel.2015.04.033
NLM
Garcia GM, Oliveira LT, Pitta I da R, Lima M do CA de, Vilela JMC, Andrade MS, Abdalla DSP, Mosqueira VCF. Improved nonclinical pharmacokinetics and biodistribution of a new PPAR pan-agonist and COX inhibitor in nanocapsule formulation [Internet]. Journal of Controlled Release. 2015 ; 209 207-218.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.jconrel.2015.04.033
Vancouver
Garcia GM, Oliveira LT, Pitta I da R, Lima M do CA de, Vilela JMC, Andrade MS, Abdalla DSP, Mosqueira VCF. Improved nonclinical pharmacokinetics and biodistribution of a new PPAR pan-agonist and COX inhibitor in nanocapsule formulation [Internet]. Journal of Controlled Release. 2015 ; 209 207-218.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.jconrel.2015.04.033
Artigo de periodico
New indole-thiazolidine attenuates atherosclerosis in LDLr−/− mice (2015)
César, Fernanda A; Rudnicki, Martina; Heras, Beatriz de Las; Boscá, Lisardo; Lima, Maria C. A; Pitta, Ivan R; Abdalla, Dulcinéia Saes Parra
Source: Vascular Pharmacology. Unidade: FCF
Subjects: ARTERIOSCLEROSE, DIABETES MELLITUS NÃO INSULINO-DEPENDENTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CÉSAR, Fernanda A et al. New indole-thiazolidine attenuates atherosclerosis in LDLr−/− mice. Vascular Pharmacology, v. 71, p. 174-180, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.vph.2015.03.009. Acesso em: 17 nov. 2024.
APA
César, F. A., Rudnicki, M., Heras, B. de L., Boscá, L., Lima, M. C. A., Pitta, I. R., & Abdalla, D. S. P. (2015). New indole-thiazolidine attenuates atherosclerosis in LDLr−/− mice. Vascular Pharmacology, 71, 174-180. doi:10.1016/j.vph.2015.03.009
NLM
César FA, Rudnicki M, Heras B de L, Boscá L, Lima MCA, Pitta IR, Abdalla DSP. New indole-thiazolidine attenuates atherosclerosis in LDLr−/− mice [Internet]. Vascular Pharmacology. 2015 ; 71 174-180.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.vph.2015.03.009
Vancouver
César FA, Rudnicki M, Heras B de L, Boscá L, Lima MCA, Pitta IR, Abdalla DSP. New indole-thiazolidine attenuates atherosclerosis in LDLr−/− mice [Internet]. Vascular Pharmacology. 2015 ; 71 174-180.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.vph.2015.03.009
Artigo de periodico
Comparative analysis of agr groups and virulence genes among subclinical and clinical mastitis Staphylococcus aureus isolates from sheep flocks (2013)
Almeida, Lara Mendes de; Almeida, Mayra Zilta P. R. B; Mendonça, Carla Lopes de; Mamizuka, Elsa Masae
Source: Brazilian Journal of Microbiology. Unidade: FCF
Subjects: STAPHYLOCOCCUS, VIRULÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Lara Mendes de et al. Comparative analysis of agr groups and virulence genes among subclinical and clinical mastitis Staphylococcus aureus isolates from sheep flocks. Brazilian Journal of Microbiology, v. 44, n. 2, p. 493-498, 2013Tradução . . Disponível em: http://www.scielo.br/pdf/bjm/v44n2/a26v44n2.pdf. Acesso em: 17 nov. 2024.
APA
Almeida, L. M. de, Almeida, M. Z. P. R. B., Mendonça, C. L. de, & Mamizuka, E. M. (2013). Comparative analysis of agr groups and virulence genes among subclinical and clinical mastitis Staphylococcus aureus isolates from sheep flocks. Brazilian Journal of Microbiology, 44( 2), 493-498. Recuperado de http://www.scielo.br/pdf/bjm/v44n2/a26v44n2.pdf
NLM
Almeida LM de, Almeida MZPRB, Mendonça CL de, Mamizuka EM. Comparative analysis of agr groups and virulence genes among subclinical and clinical mastitis Staphylococcus aureus isolates from sheep flocks [Internet]. Brazilian Journal of Microbiology. 2013 ; 44( 2): 493-498.[citado 2024 nov. 17 ] Available from: http://www.scielo.br/pdf/bjm/v44n2/a26v44n2.pdf
Vancouver
Almeida LM de, Almeida MZPRB, Mendonça CL de, Mamizuka EM. Comparative analysis of agr groups and virulence genes among subclinical and clinical mastitis Staphylococcus aureus isolates from sheep flocks [Internet]. Brazilian Journal of Microbiology. 2013 ; 44( 2): 493-498.[citado 2024 nov. 17 ] Available from: http://www.scielo.br/pdf/bjm/v44n2/a26v44n2.pdf
Artigo de periodico
Chemical synthesis, docking studies and biological effects of a pan peroxisome proliferator-activated receptor agonist and cyclooxygenase inhibitor (2013)
Santin, José Roberto; Uchôa, Flávia de Toni; Lima, Maria do Carmo Alves; Rabello, Marcelo M; Machado, Isabel Daufenback; Hernandes, Marcelo Zaldini; Amato, Angelica A; Milton, Flora Aparecida; Webb, Paul; Neves, Francisco de Assis Rocha; Galdino, Suely Lins; Pitta, Ivan da Rocha; Farsky, Sandra Helena Poliselli
Source: European Journal of Pharmaceutical Sciences. Unidade: FCF
Subjects: INFLAMAÇÃO, NEUTRÓFILOS, INTERLEUCINA 1
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTIN, José Roberto et al. Chemical synthesis, docking studies and biological effects of a pan peroxisome proliferator-activated receptor agonist and cyclooxygenase inhibitor. European Journal of Pharmaceutical Sciences, v. 48, n. 4-5, p. 689-697, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2012.12.029. Acesso em: 17 nov. 2024.
APA
Santin, J. R., Uchôa, F. de T., Lima, M. do C. A., Rabello, M. M., Machado, I. D., Hernandes, M. Z., et al. (2013). Chemical synthesis, docking studies and biological effects of a pan peroxisome proliferator-activated receptor agonist and cyclooxygenase inhibitor. European Journal of Pharmaceutical Sciences, 48( 4-5), 689-697. doi:10.1016/j.ejps.2012.12.029
NLM
Santin JR, Uchôa F de T, Lima M do CA, Rabello MM, Machado ID, Hernandes MZ, Amato AA, Milton FA, Webb P, Neves F de AR, Galdino SL, Pitta I da R, Farsky SHP. Chemical synthesis, docking studies and biological effects of a pan peroxisome proliferator-activated receptor agonist and cyclooxygenase inhibitor [Internet]. European Journal of Pharmaceutical Sciences. 2013 ; 48( 4-5): 689-697.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.ejps.2012.12.029
Vancouver
Santin JR, Uchôa F de T, Lima M do CA, Rabello MM, Machado ID, Hernandes MZ, Amato AA, Milton FA, Webb P, Neves F de AR, Galdino SL, Pitta I da R, Farsky SHP. Chemical synthesis, docking studies and biological effects of a pan peroxisome proliferator-activated receptor agonist and cyclooxygenase inhibitor [Internet]. European Journal of Pharmaceutical Sciences. 2013 ; 48( 4-5): 689-697.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.ejps.2012.12.029
Trabalho de evento-resumo
Novel arylidene-thiazolidinediones with no adipogenic effects (2013)
Silva, Jacqueline Cavalcante; Saito, Cristiane Akemi Iamamoto; César, Fernanda Andrade de; Rudnicki, Martina; Galdino, Sergio Luiz; Pitta, Ivan da Rocha; Lima, M. C; Boss, M; Knap, T; Kemmerer, M; Brüne, Bernhard; Namgaladze, Dmitry; Abdalla, Dulcinéia Saes Parra
Source: Abstracts. Conference titles: European Atherosclerosis Society Congress (EAS). Unidade: FCF
Subjects: INSULINA, HIPERGLICEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Jacqueline Cavalcante et al. Novel arylidene-thiazolidinediones with no adipogenic effects. 2013, Anais.. Gothenburg: European Atherosclerosis Society, 2013. . Acesso em: 17 nov. 2024.
APA
Silva, J. C., Saito, C. A. I., César, F. A. de, Rudnicki, M., Galdino, S. L., Pitta, I. da R., et al. (2013). Novel arylidene-thiazolidinediones with no adipogenic effects. In Abstracts. Gothenburg: European Atherosclerosis Society.
NLM
Silva JC, Saito CAI, César FA de, Rudnicki M, Galdino SL, Pitta I da R, Lima MC, Boss M, Knap T, Kemmerer M, Brüne B, Namgaladze D, Abdalla DSP. Novel arylidene-thiazolidinediones with no adipogenic effects. Abstracts. 2013 ;[citado 2024 nov. 17 ]
Vancouver
Silva JC, Saito CAI, César FA de, Rudnicki M, Galdino SL, Pitta I da R, Lima MC, Boss M, Knap T, Kemmerer M, Brüne B, Namgaladze D, Abdalla DSP. Novel arylidene-thiazolidinediones with no adipogenic effects. Abstracts. 2013 ;[citado 2024 nov. 17 ]
Trabalho de evento-resumo periodico
Role of a ppar-pan agonist and cyclooxygenase-2 inhibitor on neutrophil adhesion and migration induced by g protein-coupled receptor activation (GPCR) (2013)
Santin, José Roberto; Machado, Isabel Daufenback; Drewes, Carine Cristiane; Marcondes, Rodrigo Soares; Maia, Danielle Cavalcanti; Pitta, Ivan da Rocha; Farsky, Sandra Helena Poliselli
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences. Unidade: FCF
Subjects: NEUTRÓFILOS, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTIN, José Roberto et al. Role of a ppar-pan agonist and cyclooxygenase-2 inhibitor on neutrophil adhesion and migration induced by g protein-coupled receptor activation (GPCR). Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 17 nov. 2024. , 2013
APA
Santin, J. R., Machado, I. D., Drewes, C. C., Marcondes, R. S., Maia, D. C., Pitta, I. da R., & Farsky, S. H. P. (2013). Role of a ppar-pan agonist and cyclooxygenase-2 inhibitor on neutrophil adhesion and migration induced by g protein-coupled receptor activation (GPCR). Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Santin JR, Machado ID, Drewes CC, Marcondes RS, Maia DC, Pitta I da R, Farsky SHP. Role of a ppar-pan agonist and cyclooxygenase-2 inhibitor on neutrophil adhesion and migration induced by g protein-coupled receptor activation (GPCR). Brazilian Journal of Pharmaceutical Sciences. 2013 ; 49 40 res. FCF075.[citado 2024 nov. 17 ]
Vancouver
Santin JR, Machado ID, Drewes CC, Marcondes RS, Maia DC, Pitta I da R, Farsky SHP. Role of a ppar-pan agonist and cyclooxygenase-2 inhibitor on neutrophil adhesion and migration induced by g protein-coupled receptor activation (GPCR). Brazilian Journal of Pharmaceutical Sciences. 2013 ; 49 40 res. FCF075.[citado 2024 nov. 17 ]
Trabalho de evento-resumo
New thiazolidinediones with low adipogenic effects in mouse 3T3-L1 preadipocytes (2012)
Saito, Cristiane Akemi Iamamoto; Ferrer, Renila; Rudnicki, Martina; César, Fernanda Andrade de; Lima, Maria C. A; Galdino, Suely Lins; Pitta, Ivan da Rocha; Abdalla, Dulcinéia Saes Parra
Source: Abstracts. Conference titles: International Symposium on Atherosclerosis. Unidade: FCF
Assunto: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAITO, Cristiane Akemi Iamamoto et al. New thiazolidinediones with low adipogenic effects in mouse 3T3-L1 preadipocytes. 2012, Anais.. Sydney: Australian Atherosclerosis Society, 2012. . Acesso em: 17 nov. 2024.
APA
Saito, C. A. I., Ferrer, R., Rudnicki, M., César, F. A. de, Lima, M. C. A., Galdino, S. L., et al. (2012). New thiazolidinediones with low adipogenic effects in mouse 3T3-L1 preadipocytes. In Abstracts. Sydney: Australian Atherosclerosis Society.
NLM
Saito CAI, Ferrer R, Rudnicki M, César FA de, Lima MCA, Galdino SL, Pitta I da R, Abdalla DSP. New thiazolidinediones with low adipogenic effects in mouse 3T3-L1 preadipocytes. Abstracts. 2012 ;[citado 2024 nov. 17 ]
Vancouver
Saito CAI, Ferrer R, Rudnicki M, César FA de, Lima MCA, Galdino SL, Pitta I da R, Abdalla DSP. New thiazolidinediones with low adipogenic effects in mouse 3T3-L1 preadipocytes. Abstracts. 2012 ;[citado 2024 nov. 17 ]
Trabalho de evento-resumo
Novel thiazolidine-2,4-diones inhibit atherosclerotic lesion progression in LDL receptor-deficient mice (2012)
César, Fernanda Andrade de; Rudnicki, Martina; Saito, Cristiane Akemi Iamamoto; Galdino, Suely Lins; Pitta, Ivan Rocha; Lima, Maria C. A; Abdalla, Dulcinéia Saes Parra
Source: Abstracts. Conference titles: International Symposium on Atherosclerosis. Unidade: FCF
Subjects: ARTERIOSCLEROSE, ANTI-INFLAMATÓRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CÉSAR, Fernanda Andrade de et al. Novel thiazolidine-2,4-diones inhibit atherosclerotic lesion progression in LDL receptor-deficient mice. 2012, Anais.. Sydney: Australian Atherosclerosis Society, 2012. . Acesso em: 17 nov. 2024.
APA
César, F. A. de, Rudnicki, M., Saito, C. A. I., Galdino, S. L., Pitta, I. R., Lima, M. C. A., & Abdalla, D. S. P. (2012). Novel thiazolidine-2,4-diones inhibit atherosclerotic lesion progression in LDL receptor-deficient mice. In Abstracts. Sydney: Australian Atherosclerosis Society.
NLM
César FA de, Rudnicki M, Saito CAI, Galdino SL, Pitta IR, Lima MCA, Abdalla DSP. Novel thiazolidine-2,4-diones inhibit atherosclerotic lesion progression in LDL receptor-deficient mice. Abstracts. 2012 ;[citado 2024 nov. 17 ]
Vancouver
César FA de, Rudnicki M, Saito CAI, Galdino SL, Pitta IR, Lima MCA, Abdalla DSP. Novel thiazolidine-2,4-diones inhibit atherosclerotic lesion progression in LDL receptor-deficient mice. Abstracts. 2012 ;[citado 2024 nov. 17 ]
Trabalho de evento-resumo
Proangiogenic and anti-inflammatory properties of new thiazolidinediones in endothelial cells (2012)
Rudnicki, Martina; Saito, Cristiane Akemi Iamamoto; César, Fernanda Andrade de; Lima, Maria C. A; Galdino, Suely Lins; Pitta, Ivan da Rocha; Abdalla, Dulcinéia Saes Parra
Source: Abstracts. Conference titles: International Symposium on Atherosclerosis. Unidade: FCF
Assunto: CÉLULAS ENDOTELIAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUDNICKI, Martina et al. Proangiogenic and anti-inflammatory properties of new thiazolidinediones in endothelial cells. 2012, Anais.. Sydney: Australian Atherosclerosis Society, 2012. . Acesso em: 17 nov. 2024.
APA
Rudnicki, M., Saito, C. A. I., César, F. A. de, Lima, M. C. A., Galdino, S. L., Pitta, I. da R., & Abdalla, D. S. P. (2012). Proangiogenic and anti-inflammatory properties of new thiazolidinediones in endothelial cells. In Abstracts. Sydney: Australian Atherosclerosis Society.
NLM
Rudnicki M, Saito CAI, César FA de, Lima MCA, Galdino SL, Pitta I da R, Abdalla DSP. Proangiogenic and anti-inflammatory properties of new thiazolidinediones in endothelial cells. Abstracts. 2012 ;[citado 2024 nov. 17 ]
Vancouver
Rudnicki M, Saito CAI, César FA de, Lima MCA, Galdino SL, Pitta I da R, Abdalla DSP. Proangiogenic and anti-inflammatory properties of new thiazolidinediones in endothelial cells. Abstracts. 2012 ;[citado 2024 nov. 17 ]
Trabalho de evento-resumo periodico
New thiazolidinediones with low adipogenic effects in mouse 3T3-L1 preadipocytes (2012)
Saito, Cristiane Akemi Iamamoto; Rudnicki, Martina; César, Fernanda Andrade de; Ferrer, Renila; Galdino, Suely Lins; Pitta, Ivan da Rocha; Lima, Maria C. A; Abdalla, Dulcinéia Saes Parra
Source: Vascular Pharmacology. Conference titles: European meeting on vascular biology and medicine (EMVBM). Unidade: FCF
Assunto: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAITO, Cristiane Akemi Iamamoto et al. New thiazolidinediones with low adipogenic effects in mouse 3T3-L1 preadipocytes. Vascular Pharmacology. new york: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 17 nov. 2024. , 2012
APA
Saito, C. A. I., Rudnicki, M., César, F. A. de, Ferrer, R., Galdino, S. L., Pitta, I. da R., et al. (2012). New thiazolidinediones with low adipogenic effects in mouse 3T3-L1 preadipocytes. Vascular Pharmacology. new york: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Saito CAI, Rudnicki M, César FA de, Ferrer R, Galdino SL, Pitta I da R, Lima MCA, Abdalla DSP. New thiazolidinediones with low adipogenic effects in mouse 3T3-L1 preadipocytes. Vascular Pharmacology. 2012 ; 56( 5-6): 376 res. P.13.17.[citado 2024 nov. 17 ]
Vancouver
Saito CAI, Rudnicki M, César FA de, Ferrer R, Galdino SL, Pitta I da R, Lima MCA, Abdalla DSP. New thiazolidinediones with low adipogenic effects in mouse 3T3-L1 preadipocytes. Vascular Pharmacology. 2012 ; 56( 5-6): 376 res. P.13.17.[citado 2024 nov. 17 ]
Trabalho de evento-resumo periodico
Anti-atherogenic and anti-inflammatory effects of novel thiazolidine-2,4-diones in RAW 264.7 macrophages and in low-density lipoprotein receptor-deficient mice (2012)
Cesar, A. Fernanda; Rudnicki, Martina; Saito, Cristiane Akemi Iamamoto; Galdino, Suely Lins; Pitta, Ivan da Rocha; Lima, Maria Carmo Alves; Abdalla, Dulcinéia Saes Parra
Source: Vascular Pharmacology. Conference titles: European meeting on vascular biology and medicine (EMVBM). Unidade: FCF
Subjects: ANTI-INFLAMATÓRIOS, LIPOPROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CESAR, A. Fernanda et al. Anti-atherogenic and anti-inflammatory effects of novel thiazolidine-2,4-diones in RAW 264.7 macrophages and in low-density lipoprotein receptor-deficient mice. Vascular Pharmacology. new york: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 17 nov. 2024. , 2012
APA
Cesar, A. F., Rudnicki, M., Saito, C. A. I., Galdino, S. L., Pitta, I. da R., Lima, M. C. A., & Abdalla, D. S. P. (2012). Anti-atherogenic and anti-inflammatory effects of novel thiazolidine-2,4-diones in RAW 264.7 macrophages and in low-density lipoprotein receptor-deficient mice. Vascular Pharmacology. new york: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Cesar AF, Rudnicki M, Saito CAI, Galdino SL, Pitta I da R, Lima MCA, Abdalla DSP. Anti-atherogenic and anti-inflammatory effects of novel thiazolidine-2,4-diones in RAW 264.7 macrophages and in low-density lipoprotein receptor-deficient mice. Vascular Pharmacology. 2012 ; 56( 5-6): 371 res. P.13.2.[citado 2024 nov. 17 ]
Vancouver
Cesar AF, Rudnicki M, Saito CAI, Galdino SL, Pitta I da R, Lima MCA, Abdalla DSP. Anti-atherogenic and anti-inflammatory effects of novel thiazolidine-2,4-diones in RAW 264.7 macrophages and in low-density lipoprotein receptor-deficient mice. Vascular Pharmacology. 2012 ; 56( 5-6): 371 res. P.13.2.[citado 2024 nov. 17 ]
Trabalho de evento-resumo periodico
A novel thiazolidinedione with low activity on differentiation of mouse preosteoblasts and preadipocytes (2012)
Saito, C. A. I; Ferrer, R; César, Fernanda Andrade de; Lima, M. C. A; Galdino, Sergio Luiz; Pitta, Ivan da Rocha; Rudnicki, Martina; Abdalla, Dulcinéia Saes Parra
Source: Febs Journal. Conference titles: International Union of Biochemistry and Molecular Biology (IUBMB). Unidade: FCF
Subjects: ANTIDIABÉTICOS (HIPOGLICEMIANTES), OSTEOGÊNESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAITO, C. A. I et al. A novel thiazolidinedione with low activity on differentiation of mouse preosteoblasts and preadipocytes. Febs Journal. Malden: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 17 nov. 2024. , 2012
APA
Saito, C. A. I., Ferrer, R., César, F. A. de, Lima, M. C. A., Galdino, S. L., Pitta, I. da R., et al. (2012). A novel thiazolidinedione with low activity on differentiation of mouse preosteoblasts and preadipocytes. Febs Journal. Malden: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Saito CAI, Ferrer R, César FA de, Lima MCA, Galdino SL, Pitta I da R, Rudnicki M, Abdalla DSP. A novel thiazolidinedione with low activity on differentiation of mouse preosteoblasts and preadipocytes. Febs Journal. 2012 ; 279 562 res. P27-82.[citado 2024 nov. 17 ]
Vancouver
Saito CAI, Ferrer R, César FA de, Lima MCA, Galdino SL, Pitta I da R, Rudnicki M, Abdalla DSP. A novel thiazolidinedione with low activity on differentiation of mouse preosteoblasts and preadipocytes. Febs Journal. 2012 ; 279 562 res. P27-82.[citado 2024 nov. 17 ]
Trabalho de evento-resumo periodico
New thiazolidine-2,4-diones improve lipid profile and dow-regulate pro-inflammatory gene expression in LDL receptor-deficient mice (2011)
César, F. A; Rudnicki, Martina; Saito, C. A. I; Galdino, S. L; Lima, M. C. A; Pitta, Ivan da Rocha; Abdalla, Dulcinéia Saes Parra
Source: Atherosclerosis Supplements. Conference titles: Congress of the European-Atherosclerosis Society (EAS). Unidade: FCF
Subjects: EXPRESSÃO GÊNICA, LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CÉSAR, F. A et al. New thiazolidine-2,4-diones improve lipid profile and dow-regulate pro-inflammatory gene expression in LDL receptor-deficient mice. Atherosclerosis Supplements. Amsterdam: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 17 nov. 2024. , 2011
APA
César, F. A., Rudnicki, M., Saito, C. A. I., Galdino, S. L., Lima, M. C. A., Pitta, I. da R., & Abdalla, D. S. P. (2011). New thiazolidine-2,4-diones improve lipid profile and dow-regulate pro-inflammatory gene expression in LDL receptor-deficient mice. Atherosclerosis Supplements. Amsterdam: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
César FA, Rudnicki M, Saito CAI, Galdino SL, Lima MCA, Pitta I da R, Abdalla DSP. New thiazolidine-2,4-diones improve lipid profile and dow-regulate pro-inflammatory gene expression in LDL receptor-deficient mice. Atherosclerosis Supplements. 2011 ; 12( 1): 83 res. 387.[citado 2024 nov. 17 ]
Vancouver
César FA, Rudnicki M, Saito CAI, Galdino SL, Lima MCA, Pitta I da R, Abdalla DSP. New thiazolidine-2,4-diones improve lipid profile and dow-regulate pro-inflammatory gene expression in LDL receptor-deficient mice. Atherosclerosis Supplements. 2011 ; 12( 1): 83 res. 387.[citado 2024 nov. 17 ]
Trabalho de evento-resumo
Effects of peroxisome proliferator activated receptor gamma (PPARgamma) partial agonist LYSO-7 on ethanol/HCI-induced ulcer model (2011)
Santin, José Roberto; Machado, Isabel Daufenback; Shimoyama, A. T; Müller, G. G; Galdino, Suely Lins; Pitta, Ivan da Rocha; Farsky, Sandra Helena Poliselli
Source: Resumos. Conference titles: Reunião Anual da Federação de Sociedades de Biologia Experimental. Unidade: FCF
Subjects: ÚLCERA GÁSTRICA, NEUTRÓFILOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTIN, José Roberto et al. Effects of peroxisome proliferator activated receptor gamma (PPARgamma) partial agonist LYSO-7 on ethanol/HCI-induced ulcer model. 2011, Anais.. São Paulo: FeSBE, 2011. . Acesso em: 17 nov. 2024.
APA
Santin, J. R., Machado, I. D., Shimoyama, A. T., Müller, G. G., Galdino, S. L., Pitta, I. da R., & Farsky, S. H. P. (2011). Effects of peroxisome proliferator activated receptor gamma (PPARgamma) partial agonist LYSO-7 on ethanol/HCI-induced ulcer model. In Resumos. São Paulo: FeSBE.
NLM
Santin JR, Machado ID, Shimoyama AT, Müller GG, Galdino SL, Pitta I da R, Farsky SHP. Effects of peroxisome proliferator activated receptor gamma (PPARgamma) partial agonist LYSO-7 on ethanol/HCI-induced ulcer model. Resumos. 2011 ;[citado 2024 nov. 17 ]
Vancouver
Santin JR, Machado ID, Shimoyama AT, Müller GG, Galdino SL, Pitta I da R, Farsky SHP. Effects of peroxisome proliferator activated receptor gamma (PPARgamma) partial agonist LYSO-7 on ethanol/HCI-induced ulcer model. Resumos. 2011 ;[citado 2024 nov. 17 ]
Artigo de periodico
Impedimetric immunosensor for electronegative low density lipoprotein ('LDL POT. -') based on monoclonal antibody adsorbed on (polyvinyl formal)-gold nanoparticles matrix (2011)
Oliveira, Maria D. L; Abdalla, Dulcinéia Saes Parra ; Guilherme, Daniel Ferreira; Faulin, Tanize do Espírito Santo; Andrade, Cesar A. S
Source: Sensors and Actuators B: Chemical. Unidades: FCF, HU
Subjects: ANTICORPOS MONOCLONAIS, LIPOPROTEÍNAS LDL, NANOPARTÍCULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Maria D. L et al. Impedimetric immunosensor for electronegative low density lipoprotein ('LDL POT. -') based on monoclonal antibody adsorbed on (polyvinyl formal)-gold nanoparticles matrix. Sensors and Actuators B: Chemical, v. 155, n. 2, p. 775-781, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.snb.2011.01.046. Acesso em: 17 nov. 2024.
APA
Oliveira, M. D. L., Abdalla, D. S. P., Guilherme, D. F., Faulin, T. do E. S., & Andrade, C. A. S. (2011). Impedimetric immunosensor for electronegative low density lipoprotein ('LDL POT. -') based on monoclonal antibody adsorbed on (polyvinyl formal)-gold nanoparticles matrix. Sensors and Actuators B: Chemical, 155( 2), 775-781. doi:10.1016/j.snb.2011.01.046
NLM
Oliveira MDL, Abdalla DSP, Guilherme DF, Faulin T do ES, Andrade CAS. Impedimetric immunosensor for electronegative low density lipoprotein ('LDL POT. -') based on monoclonal antibody adsorbed on (polyvinyl formal)-gold nanoparticles matrix [Internet]. Sensors and Actuators B: Chemical. 2011 ; 155( 2): 775-781.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.snb.2011.01.046
Vancouver
Oliveira MDL, Abdalla DSP, Guilherme DF, Faulin T do ES, Andrade CAS. Impedimetric immunosensor for electronegative low density lipoprotein ('LDL POT. -') based on monoclonal antibody adsorbed on (polyvinyl formal)-gold nanoparticles matrix [Internet]. Sensors and Actuators B: Chemical. 2011 ; 155( 2): 775-781.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.snb.2011.01.046

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Normalized affiliation

Non normalized affiliation